NANOVIRICIDES, INC. NNVC Income Statement

Nanoviricides, inc. (NNVC)

Income statement / Quarterly

Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10
OPERATING EXPENSES
Revenues
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Research and development
1,012	1,482	1,542	1,310	1,657	1,411	1,530	1,291	1,639	1,451	2,293	1,559	1,261	1,452	1,526	1,067	1,152	1,282	1,386	546	916	811	2,201	625	1,130	1,174	1,013	1,359	710	1,209	980	1,582	1,011	691	638	1,652	1,114	750
Refund credit research and development costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	-42	42	0	0
Refund credit research and development costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
General and administrative
622	505	626	772	711	627	751	1,126	754	778	-46	1,056	1,036	988	969	980	937	942	1,163	576	787	876	1,592	607	620	714	551	831	533	381	547	494	325	448	665	863	384	361
Total operating expenses
1,634	1,987	2,168	2,082	2,369	2,039	2,282	2,418	2,393	2,230	2,246	2,615	2,297	2,440	2,495	2,048	2,090	2,225	2,549	1,122	1,703	1,687	3,793	1,233	1,751	1,888	1,565	2,190	1,243	1,590	1,527	2,076	1,337	1,140	1,261	2,557	1,498	1,111
LOSS FROM OPERATIONS
-1,634	-1,987	-2,168	-2,082	-2,369	-2,039	-2,282	-2,418	-2,393	-2,230	-2,246	-2,615	-2,297	-2,440	-2,495	-2,048	-2,090	-2,225	-2,549	-1,122	-1,703	-1,687	-3,793	-1,233	-1,751	-1,888	-1,565	-2,190	-1,243	-1,590	-1,527	-2,076	-1,337	-1,140	-1,261	-2,557	-1,498	-1,111
OTHER INCOME (EXPENSE):
Interest income
0	5	8	8	15	22	27	23	24	24	-	-	-	14	19	39	-4	8	-	35	-31	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest income
-	-	-	-	-	-	-	-	-	-	-	17	11	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest expense on convertible debentures
-	-	-	0	-	-	-	0	60	-	-	165	245	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	39	-	54	14	9	6	0	15	33	-13	30	20	8	7	0	3	1
Interest expense
4	-	-	-	0	-	-	-	-	125	-	-	-	245	-	301	245	245	236	1,920	247	245	120	2,725	125	120	140	822	0	0	-	-	-	-	-	-	-	-
Loss on issuance of Series A preferred stock for accounts payable - related party
142	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on extinguishment of debt
-	-	-	0	-	-	-	0	-1,348	-	-	-332	0	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Discount on convertible debentures
-	-	-	0	-	-	0	0	119	239	223	297	423	403	380	362	349	333	314	297	289	273	150	143	140	135	129	0	0	0	0	0	0	0	-	-	-	-
Beneficial conversion feature of convertible debentures
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	0	0	0	0	-	-	-	-
Non cash interest on convertible debentures
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Non cash interest expense on beneficial
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-
Non cash interest expense on beneficial conversion of convertible debentures
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Change in fair value of derivative
-147	421	-52	-65	122	175	604	284	1,100	564	20	255	1,407	13	1,457	-2,318	-85	1,487	2,065	3,054	391	3,017	-3,028	5,371	639	-4,425	-353	-669	19	-246	-103	14	-74	-8	-3	10	-80	11
Other (expense) income
-293	426	-43	-56	138	197	631	308	-403	224	-311	-522	751	-620	845	-2,943	-684	918	1,631	871	-177	2,538	-3,206	2,557	387	-4,672	-615	-1,492	35	-212	-116	44	-54	0	3	10	-76	13
LOSS BEFORE INCOME TAX PROVISION
-1,927	-1,561	-2,212	-2,139	-2,230	-1,841	-1,651	-2,109	-2,796	-2,005	-2,557	-3,138	-1,546	-3,061	-1,650	-4,991	-2,775	-1,306	-917	-251	-1,881	851	-7,000	1,323	-1,363	-6,561	-2,180	-3,682	-1,208	-1,803	-1,644	-2,031	-1,391	-1,139	-1,257	-2,546	-1,575	-1,097
INCOME TAX PROVISION
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
NET LOSS
-1,927	-1,561	-2,212	-2,139	-2,230	-1,841	-1,651	-2,109	-2,796	-2,005	-2,557	-3,138	-1,546	-3,061	-1,650	-4,991	-2,775	-1,306	-917	-251	-1,881	851	-7,000	1,323	-1,363	-6,561	-2,180	-3,682	-1,208	-1,803	-1,644	-2,031	-1,391	-1,139	-1,257	-2,546	-1,575	-1,097
NET LOSS PER COMMON SHARE
- Basic
-	-	-	-	-	-	-	-	-	-	-	61,002	58,205	58,179	57,978	57,836	57,588	57,274	57,140	56,941	56,557	55,576	-	53,318	50,031	-	-	-	-	-	-	-	-	-	-	-	-	-
- Diluted
-	-	-	-	-	-	-	-	-	-	-	61,002	58,205	58,179	57,978	57,836	57,588	57,274	62,474	59,607	59,224	55,576	-	55,033	50,031	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss per common share- basic and diluted
-0.50	-0.41	1.08	-0.03	-0.64	-0.53	-0.03	-0.03	-0.04	-0.03	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.14	-	-0.08	-0.03	-0.04	-0.12	-0.01	-0.01	-0.01	-0.12	-0.02	-0.01	-0.01
- Basic
-	-	-	-	-	-	-	-	-	-	-	-0.05	-0.03	-0.05	-0.03	-0.09	-0.05	-0.02	-0.03	0.00	-0.03	0.02	-	0.02	-0.03	-	-	-	-	-	-	-	-	-	-	-	-	-
- Diluted
-	-	-	-	-	-	-	-	-	-	-	-0.05	-0.03	-0.05	-0.03	-0.09	-0.05	-0.02	-0.05	-0.02	-0.04	0.02	-	-0.02	-0.03	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted average common shares outstanding
Weighted average common shares outstanding- basic and diluted
3,853	3,845	208,321	71,955	3,469	3,459	68,972	64,068	63,335	63,307	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	47,672	-	46,701	45,098	41,305	-272,528	151,556	147,455	144,570	-	-	-	-
Weighted average common shares outstanding: - basic and diluted (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	140,222	138,098	135,471